Literature DB >> 30890370

TMEPAI/PMEPA1 inhibits Wnt signaling by regulating β-catenin stability and nuclear accumulation in triple negative breast cancer cells.

Riezki Amalia1, Mohammed Abdelaziz2, Meidi Utami Puteri3, Jongchan Hwang3, Femmi Anwar1, Yukihide Watanabe4, Mitsuyasu Kato5.   

Abstract

Transmembrane prostate androgen-induced protein (TMEPAI) is a type I transmembrane protein induced by several intracellular signaling pathways such as androgen, TGF-β, EGF, and Wnt signaling. It has been reported that TMEPAI functions to suppress TGF-β and androgen signaling but here, we report a novel function of TMEPAI in Wnt signaling suppression. First, we show that TMEPAI significantly inhibits TCF/LEF transcriptional activity stimulated by Wnt3A, LiCl, and β-catenin. Mechanistically, TMEPAI overexpression prevented β-catenin accumulation in the nucleus and TMEPAI knockout in triple negative breast cancer cell lines promoted β-catenin stability and nuclear accumulation together with increased mRNA levels of Wnt target genes AXIN2 and c-MYC. The presence of TGF-β type I receptor kinase inhibitor did not affect the enhanced mRNA expression of AXIN2 in TMEPAI knockout cells. These data suggest that TMEPAI suppresses Wnt signaling by interfering with β-catenin stability and nuclear translocation in a TGF-β signaling-independent manner.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  TMEPAI; Wnt signaling; β-catenin

Year:  2019        PMID: 30890370     DOI: 10.1016/j.cellsig.2019.03.016

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  11 in total

1.  CSDE1 attenuates microRNA-mediated silencing of PMEPA1 in melanoma.

Authors:  Pavan Kumar Kakumani; Tanit Guitart; Francois Houle; Louis-Mathieu Harvey; Benjamin Goyer; Lucie Germain; Fátima Gebauer; Martin J Simard
Journal:  Oncogene       Date:  2021-04-08       Impact factor: 9.867

2.  Target Protein for Xklp2 Functions as Coactivator of Androgen Receptor and Promotes the Proliferation of Prostate Carcinoma Cells.

Authors:  Baisheng Sun; Yin Long; Ling Xiao; Jiazhi Wang; Qian Yi; Dali Tong; Ke Li
Journal:  J Oncol       Date:  2022-04-11       Impact factor: 4.501

3.  Role of the kringle-like domain in glycoprotein NMB for its tumorigenic potential.

Authors:  Rudy Xie; Yukari Okita; Yumu Ichikawa; Muhammad Ali Fikry; Kim Tuyen Huynh Dam; Sophie Thi PhuongDung Tran; Mitsuyasu Kato
Journal:  Cancer Sci       Date:  2019-06-26       Impact factor: 6.716

4.  Forkhead box (FOX) G1 promotes hepatocellular carcinoma epithelial-Mesenchymal transition by activating Wnt signal through forming T-cell factor-4/Beta-catenin/FOXG1 complex.

Authors:  Xingrong Zheng; Jiaxin Lin; Hewei Wu; Zhishuo Mo; Yunwen Lian; Peipei Wang; Zhaoxia Hu; Zhiliang Gao; Liang Peng; Chan Xie
Journal:  J Exp Clin Cancer Res       Date:  2019-11-27

5.  Study on the cellular internalization mechanisms and in vivo anti-bone metastasis prostate cancer efficiency of the peptide T7-modified polypeptide nanoparticles.

Authors:  Yongwei Gu; Xinmei Chen; Haiyan Zhang; Heyi Wang; Hang Chen; Sifan Huang; Youfa Xu; Yuansheng Zhang; Xin Wu; Jianming Chen
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

6.  Prostaglandin F-induced Prostate Transmembrane Protein, Androgen Induced 1 mediates ovarian cancer progression increasing epithelial plasticity.

Authors:  Alba Jiménez-Segovia; Alba Mota; Alejandro Rojo-Sebastián; Beatriz Barrocal; Angela Rynne-Vidal; María-Laura García-Bermejo; Raquel Gómez-Bris; Lukas J A C Hawinkels; Pilar Sandoval; Ramon Garcia-Escudero; Manuel López-Cabrera; Gema Moreno-Bueno; Manuel Fresno; Konstantinos Stamatakis
Journal:  Neoplasia       Date:  2019-11-14       Impact factor: 5.715

7.  Analysis of PMEPA1 Isoforms (a and b) as Selective Inhibitors of Androgen and TGF-β Signaling Reveals Distinct Biological and Prognostic Features in Prostate Cancer.

Authors:  Shashwat Sharad; Zsófia M Sztupinszki; Yongmei Chen; Claire Kuo; Lakshmi Ravindranath; Zoltan Szallasi; Gyorgy Petrovics; Taduru L Sreenath; Albert Dobi; Inger L Rosner; Alagarsamy Srinivasan; Shiv Srivastava; Jennifer Cullen; Hua Li
Journal:  Cancers (Basel)       Date:  2019-12-12       Impact factor: 6.639

8.  New insights of the correlation between AXIN2 polymorphism and cancer risk and susceptibility: evidence from 72 studies.

Authors:  Xi Li; Yiming Li; Guodong Liu; Wei Wu
Journal:  BMC Cancer       Date:  2021-04-01       Impact factor: 4.430

9.  TGF-β-Induced TMEPAI Promotes Epithelial-Mesenchymal Transition in Doxorubicin-Treated Triple-Negative Breast Cancer Cells via SMAD3 and PI3K/AKT Pathway Alteration.

Authors:  Bantari W K Wardhani; Melva Louisa; Yukihide Watanabe; Rianto Setiabudy; Mitsuyasu Kato
Journal:  Breast Cancer (Dove Med Press)       Date:  2021-09-21

10.  TGF-β-Induced TMEPAI Attenuates the Response of Triple-Negative Breast Cancer Cells to Doxorubicin and Paclitaxel.

Authors:  Bantari Wk Wardhani; Meidi Utami Puteri; Yukihide Watanabe; Melva Louisa; Rianto Setiabudy; Mitsuyasu Kato
Journal:  J Exp Pharmacol       Date:  2020-01-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.